Abstract
The purpose of this study was to evaluate the effect of selenium (Se) in the prevention of human primary liver cancer. Three intervention trials were conducted among the residents at high risk to primary liver cancer (PLC) in Qidong county, Jiang-su province, the People’s Republic of China. This area has the second highest rate of PLC in China. One trial was undertaken among the general population in a township with supplement of table salt fortified with 15 ppm anhydrous sodium selenite (Se-salt) for 5 y and the other four townships with similar PLC incidence rate served as the controls using normal table salt. The second trial was undertaken among hepatitis B virus surface antigen carriers (HBVsAg+) receiving supplement of 200 μg Se in form of selenized, yeast (Se-yeast) daily vs placebo for 4 y. The third trial was carried out in members of families with high PLC incidence using Se-yeast (200 μg of Se daily) vs placebo for 2 y. The results showed that nutritional supplement of Se could reduce the PLC incidence significantly.
Similar content being viewed by others
References
S. Y. Yu, Y. J. Zhu, and W. G. Li,Biol. Trace Element Res. 15, 231 (1988).
WHO Expert Committee on Passive Immunization against Hepatitis B. p. 204 (1977).
J. H. Watkinson,Anal. Chem. 38, 92 (1966).
Y. Cai, L. Lao, Y. Eai, and E. Shen,Tumor 6, 200 (1986) (in Chinese).
H. F. Stich, W. Stich, H. Rosin and M. O. Vallejera,Int. J. Cancer,34, 745 (1984).
G. N. Schrauzer,Advances in Nutr. Res. 2, 219 (1979).
S. Y. Yu, P. Ao, L. M. Wang, S. L. Huang, H. C. Chen, X. P. Lu, and Q. Y. Liu.Biol. Trace Element Res. 15, 243 (1988).
X. P. Lu, S. D. Liao and S. Y. Yu,Chinese Biochem. J. 5, 235 (1989).
S. Y. Yu, X. P. Lu, and S. D. Liao,Metal Ions in Biology and Medicine, P. Collery, L. A. Poirier, M. Manfait and J. C. Etienne, eds. John Libbey Eurotext, Paris (1990) p. 487.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yu, SY., Ya-Jun-Zhu, Li, WG. et al. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res 29, 289–294 (1991). https://doi.org/10.1007/BF03032685
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03032685